Ally Financial’s Edwards Lifesciences EW Stock Holding History

Ally Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Buy	26,000 +13,000	+100%	+$1.09M	0.3%	83
2026 Q1	$1.04M	Buy	+13,000	New	+$1.07M	0.13%	109
2025 Q2	–	Sell	-15,000	Closed	-$1.09M	–	110
2025 Q1	$1.09M	Hold	15,000	–	–	0.12%	95
2024 Q4	$1.11M	Hold	15,000	–	–	0.14%	89
2024 Q3	$990K	Buy	+15,000	New	+$1.09M	0.12%	98
2024 Q2	–	Sell	-6,000	Closed	-$573K	–	119
2024 Q1	$573K	Hold	6,000	–	–	0.08%	104
2023 Q4	$458K	Hold	6,000	–	–	0.06%	98
2023 Q3	$416K	Buy	+6,000	New	+$482K	0.06%	105
2014 Q2	–	Sell	-210,000	Closed	-$2.6M	–	132
2014 Q1	$2.6M	Buy	210,000 +150,000	+250%	+$1.73M	0.28%	118
2013 Q4	$658K	Buy	+60,000	New	+$676K	0.07%	121

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Ally Financial's EW Position: Q2 2026 in Review

Ally Financial increased its Edwards Lifesciences (EW) stake by 100% in Q2 2026, buying an estimated $1.09M and bringing the position to 26,000 shares worth $2.35M. The position accounts for 0.3% of the portfolio, ranked #83.

Ally Financial first reported a position in EW in Q4 2013 and has held it in 10 quarters since. The position peaked at $2.6M in Q1 2014. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Ally Financial held 26,000 shares of Edwards Lifesciences worth $2.35M as of Q2 2026.
Ally Financial bought 13,000 Edwards Lifesciences shares in Q2 2026, an estimated $1.09M.
Edwards Lifesciences made up 0.3% of Ally Financial's portfolio in Q2 2026, its #83 holding.
Ally Financial first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 10 quarters since.
Ally Financial's Edwards Lifesciences position peaked at $2.6M in Q1 2014.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ally Financial's 13F filing for Q2 2026, filed 13 Aug 2026.